Established in 1891, the Washington State Pharmacy Quality Assurance Commission (WA Pharmacy Commission) regulates the practice of pharmacy, and the distribution, manufacturing, and delivery of pharmaceuticals within and into the state. The commission protects and promotes public health and safety by issuing licenses, registrations, and certifications to qualified persons and entities and responding to complaints or reports of unprofessional conduct. The Commission is assigned the authority to enforce and change the schedule of controlled substances in Washington state.
Washington State Pharmacy Quality Assurance Commission
(WA Pharmacy Commission)
Washington State Pharmacy Quality Assurance Commission (WA Pharmacy Commission)
- No information available at this time
WA Governor - Bill Action (May 9, 2023) - SB 5367
A bill regulating products containing THC was signed, granting new authority and rulemaking mandates for WSLCB - though fewer hemp licensees may be another result of the law.
The Week Ahead (May 1, 2023)
The Governor was scheduled to take action on two cannabis bills, including the social equity program expansion, while other bodies convened to consider regular session outcomes.
WA House - Session (April 7, 2023) - SB 5367 - Second and Third Reading
The full House incorporated changes to THC legislation designed in committee and passed the measure, but only after formally ‘reconsidering’ their vote.
The Week Ahead (February 27, 2023)
After the house of origin fiscal committee cutoff, 18 cannabis bills remained active—one less than expected—as legislators prepared for floor debate over the next week and a half.
The Week Ahead (January 30, 2023)
Hearings on WSLCB THC legislation, cannabis waste, advertising, low dose products, patient arrest protections, local override, home grow, and the fate of concentrates were all scheduled.
The Week Ahead (January 23, 2023)
Legislators continued to undertake cannabis bills slowly, especially in the senate, but perennial subjects like out-of-state ownership had been positioned for consideration.
The Week Ahead (March 7, 2022)
In the final week of a contentious short session, legislators would have to sprint to pass SB 5983, a bill to protect public health but also fundamentally restructure cannabis law.
The Week Ahead (February 28, 2022)
Four synthesized cannabinoid regulation bills had been introduced after cutoff, cannabis-related amendments were in the operating budget, and new QC rules were imminent.
The Week Ahead (February 21, 2022)
As the timeline for legislation became more compressed, committees crammed bills for action - while the WSLCB cannabinoid regulation bill was granted a second chance to NTIB.
The Week Ahead (February 14, 2022)
By Tuesday evening, most bills would need to be voted out of their house of origin to continue, but three important—and contentious—cannabis-related bills remained unmoved.